Analyst firms · Raymond James · CVS

Raymond James CVS price target and rating history

CVS Health Corporation (CVS) · Consumer Staples

Raymond James rates CVS Health Corporation (CVS) Outperform with a $120 price target, as of its latest action on Feb 14, 2022. It has published 3 rating actions on CVS since November 2021, including 0 upgrades and 2 downgrades.

Current rating
Outperform
Price target
$120
Median target, all firms
Too few
Actions on CVS
3

Raymond James price target on CVS

$120$118$11520222023202420252026
Raymond James price target on CVS, each point a stated target, November 2021 to February 2022.

Every Raymond James rating on CVS

Questions about Raymond James and CVS

What is Raymond James's price target for CVS?
Raymond James's latest stated price target for CVS Health Corporation (CVS) is $120, from its action on Feb 14, 2022.
What is Raymond James's rating on CVS?
Raymond James rates CVS Outperform, a bullish rating, as of Feb 14, 2022.
When did Raymond James last change its view on CVS?
On Feb 14, 2022, Raymond James downgrades to Outperform from Strong Buy, price target $115 to $120.

More CVS rating histories

All Raymond James ratingsCVS news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.